Cargando…

Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes

BACKGROUND AND OBJECTS: Few studies focus on multimorbidity and polypharmacy in Chinese atrial fibrillation (AF) patients. We examined the impact of multimorbidity, polypharmacy, and treatment strategies on outcomes in Chinese emergency department (ED)AF patients. We also assessed factors associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Juan, Yang, Yan-min, Zhu, Jun, Zhang, Han, Shao, Xing-hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831736/ https://www.ncbi.nlm.nih.gov/pubmed/35155632 http://dx.doi.org/10.3389/fcvm.2022.806234

Ejemplares similares

Corrigendum: Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
por: Wang, Juan, et al.
Publicado: (2022)

Multimorbidity, polypharmacy and inappropriate prescribing in elderly patients with atrial fibrillation: A report from the China Atrial Fibrillation Registry Study
por: Guo, Xueyuan, et al.
Publicado: (2022)

Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2022)

Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey
por: Kozieł, Monika, et al.
Publicado: (2020)

The Characteristics, Long-Term Outcomes, Risk Factors, and Antithrombotic Therapy in Chinese Patients With Atrial Fibrillation and Bioprosthetic Valves
por: Ren, Jiameng, et al.
Publicado: (2021)

Integrated Care of Atrial Fibrillation Using the ABC (Atrial fibrillation Better Care) Pathway Improves Clinical Outcomes in Chinese Population: An Analysis From the Chinese Atrial Fibrillation Registry
por: Wang, Yu-Feng, et al.
Publicado: (2021)

Plasma Big Endothelin-1 Levels and Long-Term Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention
por: Lyu, Si-qi, et al.
Publicado: (2022)

The application and mechanism of Chinese medicine in the upstream treatment of atrial fibrillation
por: Liu, Min, et al.
Publicado: (2023)

Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population
por: Adam, Luise, et al.
Publicado: (2023)

Impact of right atrial enlargement on clinical outcome in patients with atrial fibrillation
por: Ko, Kyu-Yong, et al.
Publicado: (2022)

Evolving Antithrombotic Treatment Patterns for Patients With Nonvalvular Atrial Fibrillation and Acute Coronary Syndrome or Underwent Percutaneous Coronary Intervention in China: A Cross-Sectional Study
por: Suo, Ni, et al.
Publicado: (2022)

Sex Differences in the Outcomes of Cryoablation for Atrial Fibrillation
por: Hermida, Alexis, et al.
Publicado: (2022)

Post-operative Atrial Fibrillation Impacts on Outcomes in Transcatheter and Surgical Aortic Valve Replacement
por: Jeong, Hyung Ki, et al.
Publicado: (2021)

Not Baseline Atrial Fibrillation but New-Onset Atrial Fibrillation and the Loss of Left Atrial Function Are Essential for Predicting Poor Outcomes in Non-ischemic Cardiomyopathy
por: Okune, Mana, et al.
Publicado: (2021)

Modified Taiwan Atrial Fibrillation Score for the Prediction of Incident Atrial Fibrillation
por: Liao, Jo-Nan, et al.
Publicado: (2022)

Population pharmacokinetic analysis for dabigatran etexilate in Chinese patients with non-valvular atrial fibrillation
por: Liu, Ya-ou, et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic and Public Restrictions on Outcomes After Catheter Ablation of Atrial Fibrillation
por: Kim, Daehoon, et al.
Publicado: (2022)

Effects of the Atrial Fibrillation Better Care Pathway on Outcomes Among Clinically Complex Chinese Patients With Atrial Fibrillation With Multimorbidity and Polypharmacy: A Report From the ChiOTEAF Registry
por: Kotalczyk, Agnieszka, et al.
Publicado: (2022)

Atrial Fibrillation and Cancer
por: Hajjar, Ludhmila Abrahao, et al.
Publicado: (2021)

Impact of atrial fibrillation on outcomes in asymptomatic severe aortic stenosis: a propensity-matched analysis
por: Oguz, Didem, et al.
Publicado: (2023)

Relationship between creatinine clearance and clinical outcomes in Chinese emergency patients with atrial fibrillation
por: Wang, Juan, et al.
Publicado: (2022)

Case report: Mechanical-electric feedback and atrial fibrillation–Revelation from the treatment of a rare atrial fibrillation caused by annular constrictive pericarditis
por: Yi, Dong, et al.
Publicado: (2023)

Left atrial appendage exclusion in atrial fibrillation
por: Rozen, Guy, et al.
Publicado: (2022)

Right atrial appendage firing in atrial fibrillation
por: Baptiste, Florian, et al.
Publicado: (2022)

Effect of Air Quality on the Risk of Emergency Room Visits in Patients With Atrial Fibrillation
por: Liang, Bin, et al.
Publicado: (2021)

Epidemiology of Atrial Fibrillation and Related Myocardial Ischemia or Arrhythmia Events in Chinese Community Population in 2019
por: Li, Cheng, et al.
Publicado: (2022)

Canada-wide mixed methods analysis evaluating the reasons for inappropriate emergency department presentation in patients with a history of atrial fibrillation: the multicentre AF-ED trial
por: Hong, Kathryn Lauren, et al.
Publicado: (2020)

Validation of T-MoCA in the Screening of Mild Cognitive Impairment in Chinese Patients With Atrial Fibrillation
por: Lai, Yiwei, et al.
Publicado: (2022)

Comprehensive metabolomic characterization of atrial fibrillation
por: Lu, Chengcan, et al.
Publicado: (2022)

Epigenetic Mechanism and Therapeutic Implications of Atrial Fibrillation
por: Li, Dan, et al.
Publicado: (2022)

Editorial: Atrial fibrillation in dementia
por: Gotzmann, Michael, et al.
Publicado: (2023)

Research Progress of Myocardial Fibrosis and Atrial Fibrillation
por: Li, Guangling, et al.
Publicado: (2022)

Clinical Safety and Efficacy of Ablation for Atrial Fibrillation Patients With a History of Stroke
por: Song, Zi-liang, et al.
Publicado: (2021)

Impact of frailty on early rhythm control outcomes in older adults with atrial fibrillation: A nationwide cohort study
por: Yu, Ga-In, et al.
Publicado: (2023)

The impact of socioeconomic deprivation on the risk of atrial fibrillation in patients with diabetes mellitus: A nationwide population-based study
por: Han, Minju, et al.
Publicado: (2022)

Cryoballoon Ablation for Treatment of Atrial Fibrillation in a Chinese Population: Five-Year Outcomes and Predictors of Recurrence After a Single Procedure
por: Chen, Xiongbiao, et al.
Publicado: (2022)

Type and Severity of Migraine Determines Risk of Atrial Fibrillation in Women
por: Rhee, Tae-Min, et al.
Publicado: (2022)

Predicting Late Recurrence of Atrial Fibrillation After Radiofrequency Ablation in Patients With Atrial Fibrillation: Comparison of C2HEST and HATCH Scores
por: Han, Jingjing, et al.
Publicado: (2022)

Research progress of non-coding RNA in atrial fibrillation
por: Xue, Zongqian, et al.
Publicado: (2023)

Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation
por: Huang, Taiyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dsj0ls6kjubb6l7ruqos7pch2t